Stem Cell Transplant for Hematological Malignancy

NCT00176930 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

330

Enrollment

OTHER

Sponsor class

Stopped replaced by another study ; Trial re-written as MT2015-29

Conditions

Leukemia, Myeloid, Chronic
AML
Leukemia, Lymphocytic, Acute
MDS
Leukemia, Lymphocytic, Chronic
JMML
Hodgkin's Disease
Non-hodgkin's Lymphoma
Multiple Myeloma

Interventions

BIOLOGICAL: Stem Cell Transplant
DRUG: Cyclophosphamide
RADIATION: Total Body Irradiation
DRUG: Busulfan
DRUG: Equine ATG (ATGAM)
BIOLOGICAL: CD4+/CD25+ cells

Sponsor

Masonic Cancer Center, University of Minnesota